Routine vaccines across the life span, 2001

Journal of Family Practice

Volumn 50, Issue 10 SUPPL., 2001, Pages

  Zimmerman, Richard Kent ^a,b   Middleton, Donald B ^a   Burns, Ilene Timko ^a   Clover, Richard D ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Bacterial vaccines; Hepatitis B vaccines; Influenza vaccine; Measles vaccine; Pertussis vaccine; Pneumococcal vaccine; Poliovirus vaccine; Varicella vaccine non MESH

Indexed keywords

EID: 0010643871     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Moyer LA, Mast EE. Hepatitis B: virology, epidemiology, disease, and prevention, and an overview of viral hepatitis. Am J Prev Med 1994; 10 (Suppl):45-55.
2. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Sem Liver Dis 1991; 11:84-92.
3. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 263:1218-1222.
4. Petersen NJ, Barrett DH, Bond WW, et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 1976; 32:572-574.
5. Franks AL, Berg CJ, Kane MA, et al. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees [published erratum appears in N Engl J Med 1990; 322:280]
6. [see comments]. N Engl J Med 1989; 321:1301-1305.
7. Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992; 89:269-273.
8. Craxi A, Tine F, Vinci M, et al. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk. Am J Epidemiol 1991;134:641-650.
9. Hayashi J, Kashiwagi S, Nomura H, et al. Hepatitis B virus transmission in nursery schools. Am J Epidemiol 1987; 125:492-498.
10. Kashiwagi S, Hayashi J, Ikematsu H, et al. Transmission of hepatitis B virus among siblings. Am J Epidemiol 1984; 120:617-625.
11. Summers PR, Biswas MK, Pastorek JG, et al. The pregnant hepatitis B carrier: evidence favoring comprehensive antepartum screening. Obstet Gynecol 1987; 69:701-704.
12. Kumar ML, Dawson KV, McCullough AJ, et al. Should all pregnant women be screened for hepatitis B? Ann Intern Med 1987;107:273-277.
13. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of Hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274:1201-1208.
14. Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344:327-332.
15. Centers for Disease Control and Prevention. Recommended childhood immunization schedule-United States, 1998. MMWR 1998; 47:8-12.
16. US Preventive Services Task Force. A guide to clinical preventive services. Baltimore, Md: Williams & Wilkins; 1996.
17. West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992; 11:866-874.
18. Farizo KM, Cochi SL, Zell ER, et al. Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992; 14:708-719.
19. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases - the Pink Book. Atlanta, Ga: Department of Health and Human Services; 1997.
20. Blennow M, Granstrom M. Long term serologic follow-up after pertussis immunization. Pediatr Infect Dis J 1990; 9:21-26.
21. Centers for Disease Control and Prevention. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. MMWR 1997; 46:1-25.
22. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334:341-348.
23. Schmitt HJ, von Konig CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996; 275:37-41.
24. Trollfors B, Taranger J, Lagergard T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995; 338:1045-1050.
25. Morgan CM, Blumberg DA, Cherry JD, et al. Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children. Am J Dis Child 1990; 144:41-45.